Literature DB >> 25473236

Skin sclerosis with elevation of serum interleukin-6 that is possibly associated with immunoglobulin 4-related disease.

Sei-Ichiro Motegi1, Akihiko Uchiyama1, Kazuya Yamada1, Akihito Uehara1, Sayaka Toki1, Osamu Ishikawa1.   

Abstract

Entities:  

Year:  2014        PMID： 25473236      PMCID： PMC4252681          DOI： 10.5021/ad.2014.26.6.766

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

1.  Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.

Authors:  S Sato; M Hasegawa; K Takehara
Journal:  J Dermatol Sci       Date:  2001-10       Impact factor: 4.563

2.  Intralesional steroid-therapy-induced reduction of plasma interleukin-6 and improvement of cutaneous plasmacytosis.

Authors:  T Yamamoto; K Soejima; I Katayama; K Nishioka
Journal:  Dermatology       Date:  1995       Impact factor: 5.366

3.  High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease?

Authors:  Aya Miyagawa-Hayashino; Yumi Matsumura; Fumi Kawakami; Hideo Asada; Miki Tanioka; Akihiko Yoshizawa; Yoshiki Mikami; Hirokazu Kotani; Yasuaki Nakashima; Yoshiki Miyachi; Toshiaki Manabe
Journal:  Hum Pathol       Date:  2009-04-22       Impact factor: 3.466

4.  IgG4-related skin manifestations in patients with IgG4-related disease.

Authors:  Tetsuya Ikeda; Masahiro Oka; Hideki Shimizu; Mayumi Hatakeyama; Haruhisa Kanki; Makoto Kunisada; Goh Tsuji; Akio Morinobu; Shunichi Kumagai; Atsushi Azumi; Akira Negi; Chikako Nishigori
Journal:  Eur J Dermatol       Date:  2013-04-01       Impact factor: 3.328

5.  Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.

Authors:  Korsa Khan; Shiwen Xu; Svetlana Nihtyanova; Emma Derrett-Smith; David Abraham; Christopher P Denton; Voon H Ong
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.